Charlie Piscitello - Jul 25, 2022 Form 4 Insider Report for Acutus Medical, Inc. (AFIB)

Role: Chief People Officer
Signature: /s/ Tom Sohn as attorney-in-fact for Charlie Piscitello
Stock symbol: AFIB
Transactions as of: Jul 25, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/1/2022, 06:03 PM
Previous filing: Aug 1, 2022
Next filing: Aug 9, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AFIB	Common Stock						49.8K	Jul 25, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AFIB	Employee Stock Options (Right to Buy)	Disposed to Issuer		-51.4K	-35.04%		95.3K	Jul 25, 2022	Common Stock	51.4K	$13.38	Direct	F1
transaction	AFIB	Employee Stock Options (Right to Buy)	Award		+51.4K	+53.94%		147K	Jul 25, 2022	Common Stock	51.4K	$1.34	Direct	F1
transaction	AFIB	Employee Stock Options (Right to Buy)	Disposed to Issuer		-28K	-19.1%		119K	Jul 25, 2022	Common Stock	28K	$18.00	Direct	F2
transaction	AFIB	Employee Stock Options (Right to Buy)	Award		+28K	+23.6%		147K	Jul 25, 2022	Common Stock	28K	$1.34	Direct	F2
transaction	AFIB	Employee Stock Options (Right to Buy)	Disposed to Issuer		-34.8K	-23.72%		112K	Jul 25, 2022	Common Stock	34.8K	$13.66	Direct	F3
transaction	AFIB	Employee Stock Options (Right to Buy)	Award		+34.8K	+31.09%		147K	Jul 25, 2022	Common Stock	34.8K	$1.34	Direct	F3
transaction	AFIB	Employee Stock Options (Right to Buy)	Disposed to Issuer		-32.5K	-22.15%		114K	Jul 25, 2022	Common Stock	32.5K	$2.41	Direct	F4
transaction	AFIB	Employee Stock Options (Right to Buy)	Award		+32.5K	+28.45%		147K	Jul 25, 2022	Common Stock	32.5K	$1.34	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on September 10, 2019, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
F2	The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on August 5, 2020, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
F3	The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on April 1, 2021, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
F4	The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on February 1, 2022, with 1/2 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 12 equal monthly installments.